Randomized phase III study comparing preoperative chemoradiotherapy alone versus neoadjuvant chemotherapy with Folfirinox regimen followed by preoperative chemoradiotherapy for patients with resectable locally advanced rectal cancer. A PRODIGE –GERCOR-SFRO-GRECCAR study.

assignment_turned_inproject

Funder: Institut National du CancerProject code: INCa-DGOS-3687 Call for proposal: PHRC11

Funded under: PHRC

Randomized phase III study comparing preoperative chemoradiotherapy alone versus neoadjuvant chemotherapy with Folfirinox regimen followed by preoperative chemoradiotherapy for patients with resectable locally advanced rectal cancer. A PRODIGE –GERCOR-SFRO-GRECCAR study.

- Summary
- DMPs

Data Management Plans

Start a new DMP in Argos

Found an issue? Give us feedback

Select content type to embed

All Research products

arrow_drop_down

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=inca________::783d57ae7799ea6a94006e65590bba35&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Randomized phase III study comparing preoperative chemoradiotherapy alone versus neoadjuvant chemotherapy with Folfirinox regimen followed by preoperative chemoradiotherapy for patients with resectable locally advanced rectal cancer. A PRODIGE –GERCOR-SFRO-GRECCAR study.

Randomized phase III study comparing preoperative chemoradiotherapy alone versus neoadjuvant chemotherapy with Folfirinox regimen followed by preoperative chemoradiotherapy for patients with resectable locally advanced rectal cancer. A PRODIGE –GERCOR-SFRO-GRECCAR study.

Loading